Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	GTPase activator activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	4.14e-10	279	58	11	GO:0005096
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	1.97e-07	507	58	11	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	1.97e-07	507	58	11	GO:0030695
GeneOntologyMolecularFunction	enzyme activator activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	2.47e-06	656	58	11	GO:0008047
GeneOntologyMolecularFunction	molecular function activator activity	TBC1D3E FLT3LG TBC1D3 TBC1D3H TBC1D3L TBC1D3D WNT1 TBC1D3I GDF1 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	8.50e-06	1233	58	14	GO:0140677
GeneOntologyMolecularFunction	chondroitin sulfate binding	RTN4R RTN4RL1	4.48e-04	11	58	2	GO:0035374
GeneOntologyMolecularFunction	Roundabout binding	RTN4R RTN4RL1	5.37e-04	12	58	2	GO:0048495
GeneOntologyMolecularFunction	enzyme regulator activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D WFIKKN2 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	6.57e-04	1418	58	12	GO:0030234
GeneOntologyMolecularFunction	C-acyltransferase activity	GCAT SLC27A3	1.68e-03	21	58	2	GO:0016408
GeneOntologyBiologicalProcess	activation of GTPase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	8.06e-15	109	57	11	GO:0090630
GeneOntologyBiologicalProcess	positive regulation of GTPase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RTN4R TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	2.53e-12	244	57	12	GO:0043547
GeneOntologyBiologicalProcess	regulation of GTPase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RTN4R TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	1.02e-10	335	57	12	GO:0043087
GeneOntologyBiologicalProcess	positive regulation of hydrolase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RTN4R TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	9.28e-09	499	57	12	GO:0051345
GeneOntologyBiologicalProcess	regulation of hydrolase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RTN4R WFIKKN2 TBC1D3I TBC1D3G TBC1D3C TBC1D3B NOS3 TBC1D3K TBC1D3F	8.07e-08	878	57	14	GO:0051336
GeneOntologyBiologicalProcess	positive regulation of catalytic activity	CACNA1C TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RTN4R TBC1D3I TBC1D3G TBC1D3C TBC1D3B NOS3 TBC1D3K TBC1D3F	5.51e-07	1028	57	14	GO:0043085
GeneOntologyBiologicalProcess	positive regulation of molecular function	CACNA1C TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D WNT1 RTN4R TBC1D3I TBC1D3G TBC1D3C TBC1D3B NOS3 TBC1D3K TBC1D3F	5.26e-06	1430	57	15	GO:0044093
GeneOntologyBiologicalProcess	regulation of cyclase activity	NPFFR2 CACNA1C GRM2 NOS3	3.96e-05	69	57	4	GO:0031279
GeneOntologyBiologicalProcess	regulation of lyase activity	NPFFR2 CACNA1C GRM2 NOS3	4.95e-05	73	57	4	GO:0051339
GeneOntologyBiologicalProcess	corpus callosum development	RTN4R RTN4RL1 RTN4RL2	1.03e-04	33	57	3	GO:0022038
GeneOntologyBiologicalProcess	membrane depolarization during AV node cell action potential	CACNA1C TRPM4	1.12e-04	6	57	2	GO:0086045
Domain	TBC	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	1.55e-16	49	55	10	SM00164
Domain	RabGAP-TBC	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	3.65e-16	53	55	10	PF00566
Domain	TBC_RABGAP	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	5.46e-16	55	55	10	PS50086
Domain	Rab-GTPase-TBC_dom	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	5.46e-16	55	55	10	IPR000195
Domain	-	MRPL38 PEBP4	2.55e-05	3	55	2	3.90.280.10
Domain	PBP	MRPL38 PEBP4	2.55e-05	3	55	2	PF01161
Domain	PEBP	MRPL38 PEBP4	2.55e-05	3	55	2	IPR008914
Domain	Leu-rich_rpt	FBXL7 LRRC25 LINGO1 RTN4R RTN4RL1 RTN4RL2	1.41e-04	271	55	6	IPR001611
Domain	Cys-rich_flank_reg_C	LINGO1 RTN4R RTN4RL1 RTN4RL2	1.43e-04	90	55	4	IPR000483
Domain	LRRCT	LINGO1 RTN4R RTN4RL1 RTN4RL2	1.43e-04	90	55	4	SM00082
Domain	LRRNT	LINGO1 RTN4R RTN4RL1 RTN4RL2	1.98e-04	98	55	4	IPR000372
Domain	LRRNT	LINGO1 RTN4R RTN4RL1 RTN4RL2	1.98e-04	98	55	4	SM00013
Domain	-	FBXL7 LRRC25 LINGO1 RTN4R RTN4RL1 RTN4RL2	3.51e-04	321	55	6	3.80.10.10
Domain	L_dom-like	FBXL7 LRRC25 LINGO1 RTN4R RTN4RL1 RTN4RL2	3.94e-04	328	55	6	IPR032675
Domain	LRR_1	FBXL7 LINGO1 RTN4R RTN4RL1 RTN4RL2	4.57e-04	219	55	5	PF00560
Domain	LRR_8	LINGO1 RTN4R RTN4RL1 RTN4RL2	1.61e-03	171	55	4	PF13855
Domain	Leu-rich_rpt_typical-subtyp	LINGO1 RTN4R RTN4RL1 RTN4RL2	1.82e-03	177	55	4	IPR003591
Domain	LRR_TYP	LINGO1 RTN4R RTN4RL1 RTN4RL2	1.82e-03	177	55	4	SM00369
Domain	BTB-kelch_protein	KLHL33 KLHL22	7.12e-03	43	55	2	IPR017096
Domain	-	KLHL33 KLHL22	8.81e-03	48	55	2	2.120.10.80
Domain	Kelch-typ_b-propeller	KLHL33 KLHL22	1.14e-02	55	55	2	IPR015915
Domain	Kelch	KLHL33 KLHL22	1.27e-02	58	55	2	SM00612
Pathway	WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K	1.06e-11	99	42	9	M46448
Pubmed	TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12.	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	1.52e-31	11	60	11	16863688
Pubmed	DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.	TBC1D3E TBC1D3 TBC1D3H TBC1D3D TBC1D3G TBC1D3B TBC1D3F	5.21e-11	74	60	7	16625196
Pubmed	Agenesis of the corpus callosum in Nogo receptor deficient mice.	RTN4R RTN4RL1 RTN4RL2	4.88e-09	3	60	3	27339102
Pubmed	The nogo receptor family restricts synapse number in the developing hippocampus.	RTN4R RTN4RL1 RTN4RL2	4.88e-09	3	60	3	22325200
Pubmed	PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer.	TBC1D3 TBC1D3D TBC1D3F	1.95e-08	4	60	3	12359748
Pubmed	Amyloid Beta Peptides Block New Synapse Assembly by Nogo Receptor-Mediated Inhibition of T-Type Calcium Channels.	RTN4R RTN4RL1 RTN4RL2	1.95e-08	4	60	3	29024660
Pubmed	Identification of novel sequences in the repertoire of hypervariable TRE17 genes from immortalized nonmalignant and malignant human keratinocytes.	TBC1D3 TBC1D3D TBC1D3F	1.95e-08	4	60	3	8406013
Pubmed	The Tre2 (USP6) oncogene is a hominoid-specific gene.	TBC1D3 TBC1D3D TBC1D3C	4.87e-08	5	60	3	12604796
Pubmed	Human TRE17 oncogene is generated from a family of homologous polymorphic sequences by single-base changes.	TBC1D3 TBC1D3D TBC1D3F	4.87e-08	5	60	3	8471161
Pubmed	Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins.	RTN4R RTN4RL1 RTN4RL2	4.87e-08	5	60	3	12839991
Pubmed	Myelin-associated glycoprotein modulates apoptosis of motoneurons during early postnatal development via NgR/p75(NTR) receptor-mediated activation of RhoA signaling pathways.	RTN4R RTN4RL1 RTN4RL2	1.70e-07	7	60	3	26335717
Pubmed	LGI1 is a Nogo receptor 1 ligand that antagonizes myelin-based growth inhibition.	RTN4R RTN4RL1 RTN4RL2	1.70e-07	7	60	3	20463223
Pubmed	NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans.	RTN4R RTN4RL1 RTN4RL2	2.72e-07	8	60	3	22406547
Pubmed	Two novel mammalian Nogo receptor homologs differentially expressed in the central and peripheral nervous systems.	RTN4R RTN4RL1 RTN4RL2	2.72e-07	8	60	3	14664809
Pubmed	Inhibitory activity of myelin-associated glycoprotein on sensory neurons is largely independent of NgR1 and NgR2 and resides within Ig-Like domains 4 and 5.	RTN4R RTN4RL2	2.93e-06	2	60	2	19367338
Pubmed	Missense mutation of the reticulon-4 receptor alters spatial memory and social interaction in mice.	RTN4R RTN4RL2	2.93e-06	2	60	2	21645550
Pubmed	Nogo-receptors NgR1 and NgR2 do not mediate regulation of CD4 T helper responses and CNS repair in experimental autoimmune encephalomyelitis.	RTN4R RTN4RL2	2.93e-06	2	60	2	22096481
Pubmed	The TRPM4 channel controls monocyte and macrophage, but not neutrophil, function for survival in sepsis.	TRPM4 LYZ	2.93e-06	2	60	2	22933633
Pubmed	Nogo receptor is involved in the adhesion of dendritic cells to myelin.	RTN4R RTN4RL2	2.93e-06	2	60	2	21906273
Pubmed	Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface.	RTN4R RTN4RL2	2.93e-06	2	60	2	24956133
Pubmed	Characterization of two novel proteins, NgRH1 and NgRH2, structurally and biochemically homologous to the Nogo-66 receptor.	RTN4RL1 RTN4RL2	2.93e-06	2	60	2	12694398
Pubmed	Deletion of IL-17ra in osteoclast precursors increases bone mass by decreasing osteoclast precursor abundance.	IL17RA LYZ	8.77e-06	3	60	2	34973492
Pubmed	LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.	LINGO1 RTN4R	8.77e-06	3	60	2	14966521
Pubmed	Interleukin-17A Serves a Priming Role in Autoimmunity by Recruiting IL-1β-Producing Myeloid Cells that Promote Pathogenic T Cells.	IL17RA LYZ	8.77e-06	3	60	2	32023490
Pubmed	Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.	RTN4R RTN4RL1	8.77e-06	3	60	2	12068310
Pubmed	Cutting edge: Flt3 ligand mediates STAT3-independent expansion but STAT3-dependent activation of myeloid-derived suppressor cells.	FLT3LG LYZ	8.77e-06	3	60	2	24639346
Pubmed	Myocilin is involved in NgR1/Lingo-1-mediated oligodendrocyte differentiation and myelination of the optic nerve.	LINGO1 RTN4R	8.77e-06	3	60	2	24741044
Pubmed	Diversity of human copy number variation and multicopy genes.	TBC1D3E TBC1D3G	8.77e-06	3	60	2	21030649
Pubmed	Nogo receptor 3, a paralog of Nogo-66 receptor 1 (NgR1), may function as a NgR1 co-receptor for Nogo-66.	RTN4R RTN4RL1	8.77e-06	3	60	2	22133682
Pubmed	Wnt1 is an Lrp5-independent bone-anabolic Wnt ligand.	WNT1 LYZ	8.77e-06	3	60	2	30404864
Pubmed	B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF.	RTN4R RTN4RL1	8.77e-06	3	60	2	33536561
Pubmed	TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.	LINGO1 RTN4R	8.77e-06	3	60	2	15694322
Pubmed	Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury.	CACNA1C NOS3	8.77e-06	3	60	2	16397145
Pubmed	An age-related sprouting transcriptome provides molecular control of axonal sprouting after stroke.	RTN4R RTN4RL2	8.77e-06	3	60	2	21057507
Pubmed	Ganglioside inhibition of neurite outgrowth requires Nogo receptor function: identification of interaction sites and development of novel antagonists.	RTN4R RTN4RL2	8.77e-06	3	60	2	18411262
Pubmed	LINGO-1 protein interacts with the p75 neurotrophin receptor in intracellular membrane compartments.	LINGO1 RTN4R	8.77e-06	3	60	2	25666623
Pubmed	Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma.	IL17RA LYZ	8.77e-06	3	60	2	27411590
Pubmed	Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammation.	IL17RA LYZ	1.75e-05	4	60	2	36577385
Pubmed	Nitric oxide prevents aortic neointimal hyperplasia by controlling macrophage polarization.	LYZ NOS3	1.75e-05	4	60	2	24925976
Pubmed	Cloning and chromosomal localization of ncf4, the mouse homologue of p40-phox.	WNT1 IL2RB	1.75e-05	4	60	2	8995189
Pubmed	The deubiquitinase MYSM1 dampens NOD2-mediated inflammation and tissue damage by inactivating the RIP2 complex.	LYZ MYSM1	1.75e-05	4	60	2	30405132
Pubmed	2'-5' oligoadenylate synthetase‑like 1 (OASL1) protects against atherosclerosis by maintaining endothelial nitric oxide synthase mRNA stability.	LYZ NOS3	1.75e-05	4	60	2	36333342
Pubmed	RXRs control serous macrophage neonatal expansion and identity and contribute to ovarian cancer progression.	LYZ RXRB	1.75e-05	4	60	2	32246014
Pubmed	Neuronal Nogo-A regulates neurite fasciculation, branching and extension in the developing nervous system.	LINGO1 RTN4R	1.75e-05	4	60	2	20573699
Pubmed	Expression of Nogo receptor 1 in microglia during development and following traumatic brain injury.	LINGO1 RTN4R	2.92e-05	5	60	2	26367446
Pubmed	Inflammatory monocytes determine endothelial nitric-oxide synthase uncoupling and nitro-oxidative stress induced by angiotensin II.	LYZ NOS3	4.37e-05	6	60	2	25143378
Pubmed	Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength.	RTN4R RTN4RL2	6.11e-05	7	60	2	18337405
Pubmed	Genetic mapping of the interleukin 1 receptor alpha and beta chain genes in the mouse.	WNT1 IL2RB	8.14e-05	8	60	2	8597644
Pubmed	Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection.	FLT3LG LYZ	8.14e-05	8	60	2	25764512
Pubmed	Microbiota regulate innate immune signaling and protective immunity against cancer.	IL17RA LYZ	8.14e-05	8	60	2	33894128
Pubmed	Nogo-A and myelin-associated glycoprotein differently regulate oligodendrocyte maturation and myelin formation.	LINGO1 RTN4R	8.14e-05	8	60	2	18632947
Pubmed	Pathogenic TH17 inflammation is sustained in the lungs by conventional dendritic cells and Toll-like receptor 4 signaling.	FLT3LG IL17RA	1.05e-04	9	60	2	29154958
Pubmed	Chromosomal localization of acquired MMTV proviral integration sites in T-cell lymphomas.	WNT1 IL2RB	1.05e-04	9	60	2	9434954
Pubmed	Nogo-a regulates neural precursor migration in the embryonic mouse cortex.	LINGO1 RTN4R	1.31e-04	10	60	2	20093372
Pubmed	Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses.	FLT3LG LYZ	1.59e-04	11	60	2	25992862
Pubmed	A Liver Capsular Network of Monocyte-Derived Macrophages Restricts Hepatic Dissemination of Intraperitoneal Bacteria by Neutrophil Recruitment.	FLT3LG LYZ	1.91e-04	12	60	2	28813662
Pubmed	Deubiquitinase MYSM1 Regulates Innate Immunity through Inactivation of TRAF3 and TRAF6 Complexes.	LYZ MYSM1	1.91e-04	12	60	2	26474655
Pubmed	The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.	LMAN2L LRRC25 LINGO1 LRRN4CL RTN4R WFIKKN2 SLC27A3 PEBP4	2.80e-04	985	60	8	12975309
Pubmed	Limited proliferation capacity of aortic intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progression.	FLT3LG LYZ	3.46e-04	16	60	2	32895539
Pubmed	Causal relationship of susceptibility genes to ischemic stroke: comparison to ischemic heart disease and biochemical determinants.	HRES1 NOS3	3.46e-04	16	60	2	20161734
Pubmed	Analysis of microsatellite polymorphism in inbred knockout mice.	LYZ NOS3	5.45e-04	20	60	2	22509320
Pubmed	Brugada Syndrome	CACNA1C TRPM4	7.88e-04	24	60	2	20301690
Pubmed	A suite of new Dre recombinase drivers markedly expands the ability to perform intersectional genetic targeting.	WNT1 LYZ	1.15e-03	29	60	2	33567267
Pubmed	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	TBC1D3 TBC1D3F	1.40e-03	32	60	2	23535730
Pubmed	Role of inflammation gene polymorphisms on pain severity in lung cancer patients.	IL2RB NOS3	1.49e-03	33	60	2	19773451
Pubmed	A genome annotation-driven approach to cloning the human ORFeome.	RTN4R IL17RA IL2RB KLHL22	1.68e-03	294	60	4	15461802
Cytoband	Ensembl 112 genes in cytogenetic band chr17q12	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	1.05e-16	149	61	11	chr17q12
Cytoband	17q12	TBC1D3 TBC1D3H TBC1D3C TBC1D3B TBC1D3F	2.28e-07	99	61	5	17q12
Cytoband	Ensembl 112 genes in cytogenetic band chr22q11	RTN4R IL17RA KLHL22 FAM246C	2.37e-03	419	61	4	chr22q11
GeneFamily	Kelch like\|BTB domain containing	KLHL33 KLHL22	1.92e-03	42	28	2	617
GeneFamily	CD molecules\|I-set domain containing\|Immunoglobulin like domain containing\|Interleukin receptors\|TIR domain containing	IL17RA IL2RB	1.92e-03	42	28	2	602
GeneFamily	Endogenous ligands	FLT3LG WNT1 GDF1	5.72e-03	237	28	3	542
CoexpressionAtlas	Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	3.09e-12	90	59	9	PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05
CoexpressionAtlas	Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D RTN4RL1 IL17RA TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	1.47e-11	213	59	11	PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlas	Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D RTN4RL1 IL17RA TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	1.47e-11	213	59	11	PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlas	DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D RTN4RL1 IL17RA TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	5.80e-11	242	59	11	PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D RTN4RL1 GDF1 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	1.13e-09	320	59	11	PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D IL17RA TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	4.98e-09	281	59	10	PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D IL17RA TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	4.98e-09	281	59	10	PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D WNT1 FHOD3 GDF1 TBC1D3G TBC1D3C TBC1D3B RXRB TBC1D3K TBC1D3F	6.14e-06	1075	59	13	PCBC_ratio_ECTO_vs_DE_cfr-2X-p05
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D WNT1 RTN4RL1 FHOD3 GDF1 TBC1D3G TBC1D3C TBC1D3B RXRB TBC1D3K TBC1D3F KLHL22	7.93e-06	1466	59	15	PCBC_ratio_ECTO_vs_SC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D RTN4RL1 IL17RA TBC1D3G MIR1915HG TBC1D3C TBC1D3B TBC1D3K TBC1D3F KLHL22	1.30e-05	1153	59	13	PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05
CoexpressionAtlas	ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#3	VWA3A WNT1 FER1L4 TBC1D3C TBC1D3B UNC80 TBC1D3F	3.18e-04	471	59	7	ratio_ECTO_vs_SC_1000_K3
CoexpressionAtlas	ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000	VWA3A TBC1D3 TBC1D3H WNT1 FER1L4 RTN4RL1 TBC1D3C TBC1D3B UNC80 TBC1D3F	3.52e-04	986	59	10	PCBC_ratio_ECTO_vs_SC_1000
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Pld5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LINGO1 RTN4R RTN4RL1 FHOD3 IL17RA GRM2	6.84e-08	159	59	6	a082e770fa757c4a1d3ed13d53f83297e36faf05
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cbln4_Fezf2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LINGO1 RTN4R FHOD3 IL17RA GRM2 RTN4RL2	7.10e-08	160	59	6	d8241404d775f9a709abdf17988f36293fcf4c58
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	PRSS41 MRGPRF RTN4RL1 FHOD3 PEBP4	1.19e-06	140	59	5	5623a0a68403fc00166b7d13d13e184a718d9bdd
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	LINGO1 RTN4R RTN4RL1 GRM2 RTN4RL2	1.56e-06	148	59	5	223d6a640f3c34e73646a615593b9c0b4a4cbd6f
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tnc\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	VWA3A LINGO1 RTN4R GRM2 RTN4RL2	1.90e-06	154	59	5	0066b2b8cfc74603e97f271ef5efc7ec512110dc
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LINGO1 RTN4R FHOD3 GRM2 RTN4RL2	2.82e-06	167	59	5	f1ce6e64ebede1f3ef36fe982f46919fd1f814dd
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Col27a1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LINGO1 RTN4R RTN4RL1 IL17RA RTN4RL2	3.17e-06	171	59	5	d07e2c5f7d7f12c68860d4161d76372de174f1d8
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LINGO1 RTN4R RTN4RL1 IL17RA RTN4RL2	3.55e-06	175	59	5	c227fc5d1ccb69b82a96a6354913cafaf27d0eec
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LINGO1 RTN4R FHOD3 GRM2 RTN4RL2	4.19e-06	181	59	5	58f76bb9ea1518c2b629a0256a3f6595a9278152
ToppCell	10x3'2.3-week_12-13-Myeloid_monocytic-monocyte-CD14_monocyte\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TRPM4 LRRC25 GIMAP1 IL17RA LYZ	6.80e-06	200	59	5	4984d27b3768be3b8fca3391cd2b7ab1749e2913
ToppCell	10x3'2.3-week_14-16-Myeloid_monocytic-monocyte-CD14_monocyte\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TRPM4 LRRC25 GIMAP1 IL17RA LYZ	6.80e-06	200	59	5	527b7388700096686293f3f6b112269e87908dfa
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Npw\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RTN4R RTN4RL1 IL17RA RTN4RL2	1.54e-05	113	59	4	165de4316059222f33d1e51aeff4554037c0b937
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cpa6_Gpr88\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RTN4R IL17RA GRM2 RTN4RL2	3.78e-05	142	59	4	84742a7e35bab09ee1cca80cfe120b613d6aed6a
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G LRRC25 TARBP1 KMO	4.22e-05	146	59	4	b76110b159acd27a2c8d6a9f98336608ace1ec12
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col27a1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RTN4R IL17RA GRM2 RTN4RL2	5.19e-05	154	59	4	d22902d2922784583f7016453768ed05b14b965e
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LINGO1 RTN4R FHOD3 GRM2	5.59e-05	157	59	4	5aee90ad7aaa65fdabc23597451da5e48db8f4e6
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_OR1J1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NPFFR2 LRRN4CL WFIKKN2 LYZ	5.73e-05	158	59	4	276bb61d8da8984c1be35c7d9596772465cb8bba
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LINGO1 RTN4R FHOD3 GRM2	6.47e-05	163	59	4	1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LINGO1 RTN4R FHOD3 GRM2	6.47e-05	163	59	4	431221a41d396b09170476179590eaf8a55266d8
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G LRRC25 IL2RB KMO	6.47e-05	163	59	4	8028636632c168dc50731d0ebecaf88a70daf81d
ToppCell	Monocytes-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	LRRC25 GIMAP1 IL17RA LYZ	6.78e-05	165	59	4	83d06210a50073fbb7082eabd8298dd355c40416
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTN4R RTN4RL1 GRM2 RTN4RL2	7.11e-05	167	59	4	3dfec2fcc36caa6e394efae5e540a6fa28759977
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTN4R RTN4RL1 GRM2 RTN4RL2	7.11e-05	167	59	4	95b3b5ba3414729f0460a26a0deca48de0cbe33e
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTN4R RTN4RL1 GRM2 RTN4RL2	7.11e-05	167	59	4	9480739587d51e67a281778b9bddd7b5ffc3ad92
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LINGO1 RTN4R GRM2 RTN4RL2	7.61e-05	170	59	4	67415b098e8ba815b501e557192a9f2b10ee995a
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	LINGO1 RTN4R GRM2 RTN4RL2	8.52e-05	175	59	4	ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	LINGO1 RTN4R GRM2 RTN4RL2	8.52e-05	175	59	4	21f8f11a8b874d4f7c47931010a2535f2a5a3373
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LINGO1 RTN4R IL17RA RTN4RL2	8.71e-05	176	59	4	a1b9f8f199a028b3fa85de43fe96bc29f387bfd8
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G LRRC25 LYZ KMO	8.90e-05	177	59	4	cdad5a2f672a7f07c05669bfcaf1ec74defd3de7
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G LRRC25 LYZ KMO	8.90e-05	177	59	4	991ae76bb615392d84aeb89886148fa42c1c649c
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	LRRN4CL MRGPRF WFIKKN2 PEBP4	9.10e-05	178	59	4	cda7695411655bd6d0ba69e5041ca7530a9dad3a
ToppCell	LPS_only-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G LRRC25 LYZ KMO	9.29e-05	179	59	4	dc03b9045510eb1bb934329646bb92dd06890ce9
ToppCell	LPS_only-Myeloid-Monocytes,_Macrophages\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G LRRC25 LYZ KMO	9.29e-05	179	59	4	330c1326ba93bb8f32559ee1cc40e357cc44ad8d
ToppCell	LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G LRRC25 LYZ KMO	9.50e-05	180	59	4	97241f62ee133dcb0d4855ffda5dd1349de9f7b2
ToppCell	LPS-IL1RA-Myeloid-Monocytes,_Macrophages\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G LRRC25 LYZ KMO	9.50e-05	180	59	4	41896546cd1cc458e08c0d4e19aa4860e5d4fcd6
ToppCell	Monocytes-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	MYO1G LRRC25 GIMAP1 LYZ	9.70e-05	181	59	4	d8b98c3d9bef026a0a35948219027f27718ffbee
ToppCell	LPS-antiTNF-Myeloid-Monocytes,_Macrophages\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G LRRC25 LYZ KMO	9.91e-05	182	59	4	d5d6bc16458bc665e7ad6669040d79f73f640044
ToppCell	LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G LRRC25 LYZ KMO	9.91e-05	182	59	4	0b59ead4bb4486c7ec2ee90b94ee3a09905612c5
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	CACNA1C FBXL7 FHOD3 C1orf167	9.91e-05	182	59	4	ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8
ToppCell	Monocytes-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	MYO1G LRRC25 GIMAP1 LYZ	1.03e-04	184	59	4	d15405bf2a121570f6044546e98927b10ecc4354
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LINGO1 RTN4R IL17RA RTN4RL2	1.08e-04	186	59	4	56c139e679d640ea901ead657a8e8887e0fca098
ToppCell	Monocytes-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	MYO1G LRRC25 GIMAP1 LYZ	1.12e-04	188	59	4	756375cf9c9cccc4fb4a7f5e4756fa3fc36a7892
ToppCell	Monocytes-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	MYO1G LRRC25 GIMAP1 LYZ	1.15e-04	189	59	4	2164adbe1b0e8e4d39644546b7dfb19e9ea4f7b9
ToppCell	PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYO1G LRRC25 LYZ KMO	1.15e-04	189	59	4	31c8bc506ad69f2ed5676bd7e5319bad1075c8d8
ToppCell	Monocytes-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	LRRC25 GIMAP1 IL17RA LYZ	1.15e-04	189	59	4	22d08c7dde697f385100f72e009eeac8d19d329d
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-MPO+_mono-neutrophil\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO1G LRRC25 IL17RA LYZ	1.17e-04	190	59	4	bee9c9d0fc9cfba0a67dacc4569307cb326d489b
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO1G LRRC25 IL17RA LYZ	1.17e-04	190	59	4	57800d807785b9d539b47945a0a74631f5e88a06
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_dendritic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MYO1G LRRC25 LYZ KMO	1.19e-04	191	59	4	a5ee4d72b2311c8fa98ff73adc2499debb2014f1
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-C\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYO1G WNT1 IL2RB TBC1D3B	1.19e-04	191	59	4	95ae42d145adb478d886a2259baacc713cd6587b
ToppCell	Monocytes-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	MYO1G LRRC25 GIMAP1 LYZ	1.19e-04	191	59	4	ca0a5dc82cdef02e88fed937ca5784761896af33
ToppCell	PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_dendritic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYO1G LRRC25 LYZ KMO	1.19e-04	191	59	4	03e1ac489e918c7affc1cdc09fb3eb255bcf80e5
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MYO1G LRRC25 LYZ KMO	1.22e-04	192	59	4	d44f46352bac414b45cc749f7cbdc3a159bd7ae8
ToppCell	PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYO1G LRRC25 LYZ KMO	1.22e-04	192	59	4	6ac7ba0ef7d1b4f85dc12fa3f0ebaddc57f214a5
ToppCell	kidney_cells-Adult_normal_reference-Immune-Myeloid-Granulocytic-Neutrophil\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1G LRRC25 IL17RA LYZ	1.22e-04	192	59	4	e2fa1ba26d28953f0d35d95764b5dbe0b93a1191
ToppCell	kidney_cells-Adult_normal_reference-Immune-Myeloid-Granulocytic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1G LRRC25 IL17RA LYZ	1.22e-04	192	59	4	161f4626571b1bce5758fad1fe5ce41a4621771d
ToppCell	PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYO1G LRRC25 LYZ KMO	1.24e-04	193	59	4	b044fca95f519ff2ceb378afe40a95911931a29e
ToppCell	Monocytes\|World / lung cells shred on cell class, cell subclass, sample id	MYO1G LRRC25 GIMAP1 LYZ	1.24e-04	193	59	4	d66d3927f8fbe1544b5cfa5ee91a7f4a0ef1e810
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYO1G LRRC25 IL17RA LYZ	1.29e-04	195	59	4	f8908657db50f1c58904dd6fee4fc23f5ae3eed6
ToppCell	wk_15-18-Hematologic-Myeloid-Promonocyte-like\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MYO1G LRRC25 IL17RA LYZ	1.29e-04	195	59	4	37b4f635b71734c6e0bc808a739af4bbe6bb47f6
ToppCell	cellseq-Immune-Immune_Myeloid-iMON\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO1G LRRC25 IL17RA LYZ	1.32e-04	196	59	4	5842d6fa0c066815d7d8c7e59b192bfc72960707
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MYO1G LRRC25 LYZ KMO	1.32e-04	196	59	4	b904f3a6d6a93e149f5a1b34b6adad5c7894754d
ToppCell	cellseq-Immune-Immune_Myeloid-iMON-iMON\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO1G LRRC25 IL17RA LYZ	1.32e-04	196	59	4	8608be3c3e7fd776c5f2fae207cd0b801e138349
ToppCell	normal_Lung-Fibroblasts-Undetermined\|Fibroblasts / Location, Cell class and cell subclass	MYO1G LRRC25 LYZ IL2RB	1.32e-04	196	59	4	c3a1a9ae32f3c907b18bce7642891bebe150e2aa
ToppCell	wk_15-18-Hematologic-Myeloid-S100A12-hi_cla._mono.\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MYO1G LRRC25 IL17RA LYZ	1.32e-04	196	59	4	aa53ae1e5d08d31cfd81b7fae46c2b5d21d4f9b2
ToppCell	Fetal_29-31_weeks-Immune-monocyte\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO1G LRRC25 IL17RA LYZ	1.34e-04	197	59	4	48a8169a4d33c6a68d66bcd936861c75cb4b60ef
ToppCell	18-Airway-Immune\|Airway / Age, Tissue, Lineage and Cell class	MYO1G FLT3LG GIMAP1 IL2RB	1.34e-04	197	59	4	b28dd2aecb0658fbf48db06b675ed466d08d04eb
ToppCell	Fetal_29-31_weeks-Immune-monocyte-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO1G LRRC25 IL17RA LYZ	1.34e-04	197	59	4	8b9a88fb671d5c2b25d291c851e2b8a478f2610c
ToppCell	LPS_IL1RA-Hematopoietic_Myeloid-Monocytes,_Macrophages\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYO1G LRRC25 LYZ KMO	1.37e-04	198	59	4	7490b30462d03b5edee3bcacdef9483dd15821b5
ToppCell	LPS_only-Hematopoietic_Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS_only / Treatment groups by lineage, cell group, cell type	MYO1G LRRC25 LYZ KMO	1.37e-04	198	59	4	2985c80e656e483866c696fa08c38af90311cd66
ToppCell	(7)_Epithelial_cells-(7)_Epithelial-D_(AT2)\|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	C1orf167 LYZ SLC27A3 PEBP4	1.37e-04	198	59	4	963b7ff8c5322d9290bbaf42137bb8fdd0672db9
ToppCell	LPS_IL1RA-Hematopoietic_Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYO1G LRRC25 LYZ KMO	1.37e-04	198	59	4	4f86ff6ba8cbe987e7541fca4f3ae8d0e434677d
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Myeloid-Monocytes,_Macrophages\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYO1G LRRC25 LYZ KMO	1.37e-04	198	59	4	c3949970cfe0cb928293ad6627aeed3ed2741b95
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO1G LRRC25 IL17RA LYZ	1.37e-04	198	59	4	d5c816fb894f55acbbab188e6262668acc422fb9
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYO1G LRRC25 LYZ KMO	1.37e-04	198	59	4	57cfc1cc8b332a88e7cac7f6f042b3ffd498a1b9
ToppCell	LPS_only-Hematopoietic_Myeloid-Monocytes,_Macrophages\|LPS_only / Treatment groups by lineage, cell group, cell type	MYO1G LRRC25 LYZ KMO	1.37e-04	198	59	4	5d48539999d7a17f4165f612bf68be26c085e501
ToppCell	LPS_anti-TNF-Hematopoietic_Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO1G LRRC25 LYZ KMO	1.37e-04	198	59	4	39e52fcd467b8041da977cfe25764df02a87990a
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO1G LRRC25 IL17RA LYZ	1.37e-04	198	59	4	a7145565703d0e036d2dcef5dba6d86f200845c9
ToppCell	LPS_anti-TNF-Hematopoietic_Myeloid-Monocytes,_Macrophages\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO1G LRRC25 LYZ KMO	1.37e-04	198	59	4	b32ca1b5d88b13a39f2cd4e129ea031f97475d29
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO1G LRRC25 IL17RA LYZ	1.37e-04	198	59	4	273a9e24438c31c1d3fc3ad71efbfafb54747476
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO1G LRRC25 IL17RA LYZ	1.37e-04	198	59	4	9375a9fd31393709e1e3078f4b130e9e71a37c13
ToppCell	10x5'v1-week_12-13-Myeloid_monocytic\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MYO1G LRRC25 IL17RA LYZ	1.40e-04	199	59	4	3d6fa56da7b6bc1e045f80ddfe460d2d5715567e
ToppCell	Skin-Mesangial\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	WNT1 MRGPRF NOS3 PEBP4	1.40e-04	199	59	4	bcb78838a91cc7828680fb413fbacdb091c5fac0
ToppCell	10x5'v1-week_14-16-Myeloid_monocytic\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MYO1G TRPM4 IL17RA LYZ	1.40e-04	199	59	4	5caaf66b6cddcc8f0d0aee3c9ba80d02075e87e5
ToppCell	10x5'v1-week_14-16-Myeloid_monocytic-monocyte\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MYO1G TRPM4 IL17RA LYZ	1.40e-04	199	59	4	7f5d47e49776114d9f4a42017fead9eeb415a94c
ToppCell	PBMC-Control-cDC_0\|Control / Compartment, Disease Groups and Clusters	MYO1G GIMAP1 IL17RA LYZ	1.40e-04	199	59	4	ebf03979ef56e978d72db475bb635b43b9cbe402
ToppCell	10x5'v1-week_12-13-Myeloid_monocytic-monocyte\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MYO1G LRRC25 IL17RA LYZ	1.40e-04	199	59	4	3a50ca40f6147fac7ce0d201717781d3939bbebe
ToppCell	Tracheal-10x5prime-Immune_Myeloid\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MYO1G LRRC25 LYZ KMO	1.42e-04	200	59	4	fc6aebc20ecaa67606154540a691242dc0aea867
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO1G LRRC25 IL17RA LYZ	1.42e-04	200	59	4	47abc2ebf5d6575af59aa044b584acf63a463bbb
ToppCell	Biopsy_Control_(H.)-Immune-Monocytes\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	MYO1G LRRC25 IL17RA LYZ	1.42e-04	200	59	4	c58a5dc0a0d74a21ca15ee8b7a0197de32afa045
ToppCell	10x5'v1-week_14-16-Myeloid_monocytic-monocyte-CD14_monocyte\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TRPM4 LRRC25 IL17RA LYZ	1.42e-04	200	59	4	f65837b51bce94c08125b1a2e1a696a15267f64b
ToppCell	15-Distal-Immune\|Distal / Age, Tissue, Lineage and Cell class	MYO1G LRRC25 LYZ IL2RB	1.42e-04	200	59	4	b7083124869791280a2235f484f3659a91dd3600
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	LRRN4CL WFIKKN2 PEBP4	2.72e-04	95	59	3	3699ea16660a22ea79fecfea56ece2dfb0f13467
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	LRRN4CL WFIKKN2 PEBP4	2.72e-04	95	59	3	cbfe615d880913bafaf5e7e8d24c3ec14a9351ce
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	LRRN4CL WFIKKN2 PEBP4	2.72e-04	95	59	3	27ac23b87747434a3084cc087e7b884e68f0eab9
Disease	quinolinate measurement	ATXN2 KMO	5.88e-05	7	50	2	EFO_0800175
Disease	macrophage inflammatory protein 1b measurement	TBC1D3 GRM2 TBC1D3B TBC1D3F	8.43e-05	136	50	4	EFO_0008219
Disease	lymphocyte:monocyte ratio	MYO1G LRRC25 ATXN2 IL17RA LYZ	1.27e-04	288	50	5	EFO_0600088
Disease	right ventricular stroke volume measurement	ATXN2 NOS3	1.84e-04	12	50	2	EFO_0021817
Disease	Depression, Bipolar	CACNA1C LMAN2L KMO	3.31e-04	79	50	3	C0005587
Disease	monocyte measurement	MYO1G ATXN2 LYZ	3.69e-04	82	50	3	EFO_0803547
Disease	C-C motif chemokine 3 measurement	ATXN2 TBC1D3B	4.23e-04	18	50	2	EFO_0008051
Disease	neutrophil count, eosinophil count	MYO1G LRRC25 ATXN2 LYZ	4.69e-04	213	50	4	EFO_0004833, EFO_0004842
Disease	Calcium channel blocker use measurement	CACNA1C ATXN2 LYZ NOS3	4.69e-04	213	50	4	EFO_0009930
Disease	CCL4 measurement	TBC1D3 TBC1D3F	5.24e-04	20	50	2	EFO_0004751
Disease	neutrophil count, basophil count	MYO1G LRRC25 ATXN2 LYZ	5.66e-04	224	50	4	EFO_0004833, EFO_0005090
Disease	gastric ulcer (biomarker_via_orthology)	IDUA NOS3	5.79e-04	21	50	2	DOID:10808 (biomarker_via_orthology)
Disease	Immunologic Deficiency Syndromes	CACNA1C MYSM1	6.96e-04	23	50	2	C0021051
Disease	Brugada Syndrome (disorder)	CACNA1C TRPM4	7.58e-04	24	50	2	C1142166
Disease	granulocyte count	MYO1G LRRC25 ATXN2 LYZ	9.05e-04	254	50	4	EFO_0007987
Disease	right ventricular diastolic volume measurement	ATXN2 NOS3	1.03e-03	28	50	2	EFO_0021814
Disease	Antihypertensive use measurement	CACNA1C ATXN2 SRBD1 NOS3	1.06e-03	265	50	4	EFO_0009927
Disease	diastolic blood pressure, alcohol drinking	ATXN2 C1orf167 NOS3	1.07e-03	118	50	3	EFO_0004329, EFO_0006336
Disease	granulocyte percentage of myeloid white cells	MYO1G LRRC25 IL17RA LYZ	1.10e-03	268	50	4	EFO_0007997
Disease	pappalysin‐1 measurement	ATXN2 RTN4RL2	1.11e-03	29	50	2	EFO_0010618
Disease	systolic blood pressure, alcohol drinking	ATXN2 C1orf167 NOS3	1.35e-03	128	50	3	EFO_0004329, EFO_0006335
Disease	monocyte percentage of leukocytes	MYO1G FLT3LG LRRC25 ATXN2 IL17RA LYZ	1.42e-03	731	50	6	EFO_0007989
Disease	right ventricular systolic volume measurement	ATXN2 FHOD3	1.62e-03	35	50	2	EFO_0021815

Protein segments in the cluster

Peptide	Gene	Start	Entry
CRRAWRQCARSWAPG	FAM246C	121	P0DSO1
AWDRTCRAVLGLWRQ	C1orf167	931	Q5SNV9
WAQERGWRLARDALC	C1orf167	956	Q5SNV9
RNPWFREFWEQRFRC	GRM2	341	Q14416
CRARSLWEWLQRFRG	RTN4RL1	261	Q86UN2
DCRARPLWAWFQRAR	RTN4RL2	266	Q86UN3
CCRRAWWILVPAADR	NPFFR2	81	Q9Y5X5
PSGWRTAERRRGWRC	MIR1915HG	6	Q5T4H9
LDRFRDWQVRCPDWF	IL17RA	571	Q96F46
RQPSRAVWWARAFRC	KLHL33	226	A6NCF5
WHFCLRDRWGCPRRA	LRRN4CL	216	Q8ND94
PQGIRAWVAWRNRCQ	LYZ	121	P61626
AWVAWRNRCQNRDVR	LYZ	126	P61626
WRCRVARSRELNKPW	LRRC25	191	Q8N386
ESRRFAAARWPGWRS	ATXN2	16	Q99700
RCNLFRCRRLRGWWP	FER1L4	1636	A9Z1Z3
AAWARNASWPRSLRL	GDF1	201	P27539
AAWCLHWQRTRRRTP	FLT3LG	201	P49771
WRENFPLCGRDVARW	MTG1	16	Q9BT17
SRAEPRQRFWRHWLV	PEBP4	101	Q96S96
WQQWRRCLSARDGSR	LMAN2L	11	Q9H0V9
LACDCRLLWVFRRRW	LINGO1	371	Q96FE5
LWRCALRWAERQVGA	HRES1	201	P13985
AWRAALFWVPRGRRA	GCAT	6	O75600
ARWPRCLQRWPSQER	MAB21L3	201	Q8N8X9
QAWRNAPRCVGRIQW	NOS3	176	P29474
WPWQASLRLRRRHRC	PRSS41	66	Q7RTY9
RVAARVQRRPWGAWL	GIMAP1	246	Q8WWP7
ESRCWRYDPRHNRWF	KLHL22	366	Q53GT1
LRLRRPWNWIAHFRN	KMO	451	O15229
WRRWNRFCRRKCRAA	CACNA1C	506	Q13936
RCARVCRRWYNLAWD	FBXL7	136	Q9UJT9
CRRWYNLAWDPRLWR	FBXL7	141	Q9UJT9
WPCKNNRRCREFLWS	FHOD3	906	Q2V2M9
VHAWPDRRRWNQTCE	IL2RB	61	P14784
AARALWPLRRFWRST	IDUA	36	P35475
QRIYCPDSRGRWWDR	FAN1	696	Q9Y2M0
CRARPLWAWLQKFRG	RTN4R	266	Q9BZR6
RCASVIFPAWYWRRR	MRGPRF	141	Q96AM1
TLRCAAAPLRAWAWR	RUSC1-AS1	201	Q66K80
WARFCNRFVDTWARD	TBC1D3L	321	B9A6J9
EFCRWCIQNRWRPRS	SRBD1	461	Q8N5C6
WRRRRPWLDPAAAAA	RXRB	36	P28702
RCWARCRDWRRMALV	RNF223	186	E7ERA6
WARFCNRFVDTWARD	TBC1D3B	321	A6NDS4
WARFCNRFVDTWARD	TBC1D3H	321	P0C7X1
ARFVHRCNRGNWPEW	UNC80	1226	Q8N2C7
MAAPWWRAALCECRR	MRPL38	1	Q96DV4
WRAALCECRRWRGFS	MRPL38	6	Q96DV4
WARFCNRFVDTWARD	TBC1D3F	321	A6NER0
NRAARAFLRALGWDW	SLC27A3	101	Q5K4L6
WARFCNRFVDTWARD	TBC1D3E	321	A0A087X179
RECKWQFRNRRWNCP	WNT1	91	P04628
WARFCNRFVDTWARD	TBC1D3D	321	A0A087WVF3
GPDARRCWRFWRTVQ	TARBP1	256	Q13395
WARFCNRFVDTWARD	TBC1D3G	321	Q6DHY5
WARFCNRFVDTWARD	TBC1D3	321	Q8IZP1
WARFCNRFVDTWARD	TBC1D3K	321	A0A087X1G2
RRCLRRWFHFWGAPV	TRPM4	766	Q8TD43
LQSAWRWALNLRCRG	VWA3A	571	A6NCI4
WARFCNRFVDTWARD	TBC1D3I	321	A0A087WXS9
WARFCNRFVDTWARD	TBC1D3C	321	Q6IPX1
MWAPRCRRFWSRWEQ	WFIKKN2	1	Q8TEU8
CRRFWSRWEQVAALL	WFIKKN2	6	Q8TEU8
RQDWGCRRAWARDYL	MYO1G	826	B0I1T2
RRRRVRDPWGNWCDA	MYSM1	501	Q5VVJ2